España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Amgen
AMGN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$274.81
2.70
0.99%
At close: -
$274.70
-0.11
-0.04%
After Hours: 5:43 PM EDT
Get Report
Comment
Q4 2024 Earnings in 13 days from now on Tue Feb 4th, after the market close
Amgen (AMGN) Forecast
News
Earnings
Amgen (AMGN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Amgen (NASDAQ:AMGN) Stock
Amgen Stock (NASDAQ: AMGN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, January 17, 2025
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
Vandana Singh
FDA Approves Amgen Treatment For Pretreated Colorectal Cancer With Certain Mutation
Vandana Singh
'Ozempic Is In The Next Round Of Medicare Dru...
Benzinga Newsdesk
Amgen Announced FDA Approval Of LUMAKRAS Comb...
Benzinga Newsdesk
Monday, January 13, 2025
Unpacking the Latest Options Trading Trends in Amgen
Benzinga Insights
Peering Into Amgen's Recent Short Interest
Benzinga Insights
Friday, January 10, 2025
Wells Fargo Maintains Equal-Weight on Amgen, ...
Benzinga Newsdesk
Thursday, January 09, 2025
Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
Vandana Singh
Wednesday, January 08, 2025
Asher Bio Announces Clinical Trial Collaborat...
Benzinga Newsdesk
Truist Securities Maintains Hold on Amgen, Lo...
Benzinga Newsdesk
Monday, January 06, 2025
UK Greenlights Amgen's Drug For Aggressive Lung Cancer In Pretreated Patients
Vandana Singh
Amgen's IMDYLLTRA Approved in UK for Advanced...
Benzinga Newsdesk
Friday, January 03, 2025
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Avi Kapoor
Thursday, January 02, 2025
Analyst Expectations For Amgen's Future
Benzinga Insights
Piper Sandler Maintains Overweight on Amgen, ...
Benzinga Newsdesk
Tuesday, December 31, 2024
Dogs Of The Dow: Top 10 High-Yield Stocks Offering Dividends Up To 6.8% In 2025
Chris Katje
Friday, December 27, 2024
Looking At Amgen's Recent Unusual Options Activity
Benzinga Insights
Thursday, December 26, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Monday, December 23, 2024
Schwab US Dividend Equity ETF Reverses In December: What's Going On?
Erica Kollmann
Spotlight on Amgen: Analyzing the Surge in Options Activity
Benzinga Insights
Friday, December 20, 2024
What's Going On With Amgen Stock On Friday?
Vandana Singh
CORRECTION: Amgen shares are trading higher. ...
Benzinga Newsdesk
Friday, December 13, 2024
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
Vandana Singh
"Weight-Loss Drug Craze Appears To Be Curbing...
Benzinga Newsdesk
Thursday, December 12, 2024
Unpacking the Latest Options Trading Trends in Amgen
Benzinga Insights
Wednesday, December 11, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Tuesday, December 10, 2024
Amgen Boosts Q1 Dividend By 6% From $2.25 To ...
Benzinga Newsdesk
Demystifying Amgen: Insights From 13 Analyst Reviews
Benzinga Insights
B of A Securities Reinstates Underperform on ...
Benzinga Newsdesk
Saturday, December 07, 2024
Amgen Announced Blincyto Added To Chemotherap...
Benzinga Newsdesk
Thursday, December 05, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Amgen Announces A $1B Expansion To Establish ...
Benzinga Newsdesk
Tuesday, December 03, 2024
'ADA Advises Against Using Compounded GLP-1 R...
Benzinga Newsdesk
Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance
Surbhi Jain
Monday, December 02, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Wednesday, November 27, 2024
RBC Capital Maintains Outperform on Amgen, Lo...
Benzinga Newsdesk
Tuesday, November 26, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Stocks Mixed Ahead Of Fed Minutes, Mexican Peso Tumbles To Over 2-Year Lows On Tariff Fears: What's Driving Markets Tuesday?
Piero Cingari
Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs
Vandana Singh
Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau
Vandana Singh
Amgen shares are trading lower following the ...
Benzinga Newsdesk
Amgen Announced Data At 52 Weeks In Phase 2 S...
Benzinga Newsdesk
Thursday, November 21, 2024
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
Surbhi Jain
Wednesday, November 20, 2024
Decoding Amgen's Options Activity: What's the Big Picture?
Benzinga Insights
Tuesday, November 19, 2024
Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst
Vandana Singh
Monday, November 18, 2024
Neurogene, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
Dow Tumbles Over 300 Points Following Economic Reports, Nvidia, Microsoft Decline: Fear & Greed Index Moves To 'Neutral' Zone
Avi Kapoor
Friday, November 15, 2024
Shares of pharmaceutical and healthcare stock...
Benzinga Newsdesk
Wolfe Research Initiates Coverage On Amgen wi...
Benzinga Newsdesk
Thursday, November 14, 2024
Amgen To Present MITIGATE Phase 3 Study At AC...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch